Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1995 Sep;69(9):5261–5268. doi: 10.1128/jvi.69.9.5261-5268.1995

Involvement of a spliced and defective human foamy virus in the establishment of chronic infection.

A Saïb 1, M H Koken 1, P van der Spek 1, J Périès 1, H de Thé 1
PMCID: PMC189359  PMID: 7636968

Abstract

Human foamy retrovirus (HFV) is found as two proviruses (HFV and delta HFV) which differ by a splice-induced deletion within the bel1 transactivator gene. The defective delta HFV (which lacks a functional Bel1 but harbors an intronless bet gene) is predominantly found in nonlytic infections in vitro as well as in vivo. Here, we show that infection of cell lines stably transduced by delta HFV DNA with the highly lytic HFV leads to chronic infections characterized by an absence of lysis, a balanced ratio of HFV to delta HFV, and a persistent Bet expression accompanied by a shutoff of structural genes. While this system only partially reflects the natural situation, in which target cells are infected by HFV and delta HFV simultaneously, it strongly suggests that delta HFV is a defective interfering retrovirus. Accordingly, previous or concomitant exposure to delta HFV viruses greatly enhances the formation of lysis-resistant clones in culture after HFV infection. The inability of delta HFV proviruses encoding a mutated bet gene to induce chronic infection suggests a role for Bet in this process. Through a specific, splice-induced, genomic deletion, resulting in a switch from Bel1 to Bet expression, the lytic properties of HFV are progressively lost. Such programmed inactivation of a key gene represents a new regulatory mechanism of gene expression in retroviruses.

Full Text

The Full Text of this article is available as a PDF (970.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aguzzi A. The foamy virus family: molecular biology, epidemiology and neuropathology. Biochim Biophys Acta. 1993 May 25;1155(1):1–24. doi: 10.1016/0304-419x(93)90019-9. [DOI] [PubMed] [Google Scholar]
  2. Benham F. J., Hodgkinson S., Davies K. E. A glyceraldehyde-3-phosphate dehydrogenase pseudogene on the short arm of the human X chromosomes defines a multigene family. EMBO J. 1984 Nov;3(11):2635–2640. doi: 10.1002/j.1460-2075.1984.tb02186.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bernier R., Tremblay M. Homologous interference resulting from the presence of defective particles of human immunodeficiency virus type 1. J Virol. 1995 Jan;69(1):291–300. doi: 10.1128/jvi.69.1.291-300.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bothe K., Aguzzi A., Lassmann H., Rethwilm A., Horak I. Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes. Science. 1991 Aug 2;253(5019):555–557. doi: 10.1126/science.1650034. [DOI] [PubMed] [Google Scholar]
  5. Brenner S. Phosphotransferase sequence homology. Nature. 1987 Sep 3;329(6134):21–21. doi: 10.1038/329021a0. [DOI] [PubMed] [Google Scholar]
  6. Butera S. T., Roberts B. D., Lam L., Hodge T., Folks T. M. Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency. J Virol. 1994 Apr;68(4):2726–2730. doi: 10.1128/jvi.68.4.2726-2730.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cabot E. L., Beckenbach A. T. Simultaneous editing of multiple nucleic acid and protein sequences with ESEE. Comput Appl Biosci. 1989 Jul;5(3):233–234. doi: 10.1093/bioinformatics/5.3.233. [DOI] [PubMed] [Google Scholar]
  8. Flügel R. M. Spumaviruses: a group of complex retroviruses. J Acquir Immune Defic Syndr. 1991;4(8):739–750. [PubMed] [Google Scholar]
  9. Gallaher W. R. Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell. 1987 Jul 31;50(3):327–328. doi: 10.1016/0092-8674(87)90485-5. [DOI] [PubMed] [Google Scholar]
  10. Garcia-Blanco M. A., Cullen B. R. Molecular basis of latency in pathogenic human viruses. Science. 1991 Nov 8;254(5033):815–820. doi: 10.1126/science.1658933. [DOI] [PubMed] [Google Scholar]
  11. Giron M. L., Rozain F., Debons-Guillemin M. C., Canivet M., Peries J., Emanoil-Ravier R. Human foamy virus polypeptides: identification of env and bel gene products. J Virol. 1993 Jun;67(6):3596–3600. doi: 10.1128/jvi.67.6.3596-3600.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. He F., Sun J. D., Garrett E. D., Cullen B. R. Functional organization of the Bel-1 trans activator of human foamy virus. J Virol. 1993 Apr;67(4):1896–1904. doi: 10.1128/jvi.67.4.1896-1904.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Herchenröder O., Renne R., Loncar D., Cobb E. K., Murthy K. K., Schneider J., Mergia A., Luciw P. A. Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology. 1994 Jun;201(2):187–199. doi: 10.1006/viro.1994.1285. [DOI] [PubMed] [Google Scholar]
  14. Hope T. J., Bond B. L., McDonald D., Klein N. P., Parslow T. G. Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif. J Virol. 1991 Nov;65(11):6001–6007. doi: 10.1128/jvi.65.11.6001-6007.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kaper J. M., Tousignant M. E., Steen M. T. Cucumber mosaic virus-associated RNA 5. XI. Comparison of 14 CARNA 5 variants relates ability to induce tomato necrosis to a conserved nucleotide sequence. Virology. 1988 Apr;163(2):284–292. doi: 10.1016/0042-6822(88)90268-1. [DOI] [PubMed] [Google Scholar]
  16. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  17. Lee A. H., Lee H. Y., Sung Y. C. The gene expression of human foamy virus does not require a post-transcriptional transactivator. Virology. 1994 Oct;204(1):409–413. doi: 10.1006/viro.1994.1545. [DOI] [PubMed] [Google Scholar]
  18. Lee K. J., Lee A. H., Sung Y. C. Multiple positive and negative cis-acting elements that mediate transactivation by bel1 in the long terminal repeat of human foamy virus. J Virol. 1993 Apr;67(4):2317–2326. doi: 10.1128/jvi.67.4.2317-2326.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Luo Y., Yu H., Peterlin B. M. Cellular protein modulates effects of human immunodeficiency virus type 1 Rev. J Virol. 1994 Jun;68(6):3850–3856. doi: 10.1128/jvi.68.6.3850-3856.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Löchelt M., Muranyi W., Flügel R. M. Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7317–7321. doi: 10.1073/pnas.90.15.7317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Löchelt M., Zentgraf H., Flügel R. M. Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene. Virology. 1991 Sep;184(1):43–54. doi: 10.1016/0042-6822(91)90820-2. [DOI] [PubMed] [Google Scholar]
  22. Malim M. H., Böhnlein S., Fenrick R., Le S. Y., Maizel J. V., Cullen B. R. Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species. Proc Natl Acad Sci U S A. 1989 Nov;86(21):8222–8226. doi: 10.1073/pnas.86.21.8222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Martins L. P., Chenciner N., Asjö B., Meyerhans A., Wain-Hobson S. Independent fluctuation of human immunodeficiency virus type 1 rev and gp41 quasispecies in vivo. J Virol. 1991 Aug;65(8):4502–4507. doi: 10.1128/jvi.65.8.4502-4507.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Maurer B., Bannert H., Darai G., Flügel R. M. Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J Virol. 1988 May;62(5):1590–1597. doi: 10.1128/jvi.62.5.1590-1597.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mergia A. Simian foamy virus type 1 contains a second promoter located at the 3' end of the env gene. Virology. 1994 Feb 15;199(1):219–222. doi: 10.1006/viro.1994.1114. [DOI] [PubMed] [Google Scholar]
  26. Meyerhans A., Cheynier R., Albert J., Seth M., Kwok S., Sninsky J., Morfeldt-Månson L., Asjö B., Wain-Hobson S. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell. 1989 Sep 8;58(5):901–910. doi: 10.1016/0092-8674(89)90942-2. [DOI] [PubMed] [Google Scholar]
  27. Mosca J. D., Bednarik D. P., Raj N. B., Rosen C. A., Sodroski J. G., Haseltine W. A., Pitha P. M. Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus. Nature. 1987 Jan 1;325(6099):67–70. doi: 10.1038/325067a0. [DOI] [PubMed] [Google Scholar]
  28. Muranyi W., Flügel R. M. Analysis of splicing patterns of human spumaretrovirus by polymerase chain reaction reveals complex RNA structures. J Virol. 1991 Feb;65(2):727–735. doi: 10.1128/jvi.65.2.727-735.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pomerantz R. J., Trono D., Feinberg M. B., Baltimore D. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell. 1990 Jun 29;61(7):1271–1276. doi: 10.1016/0092-8674(90)90691-7. [DOI] [PubMed] [Google Scholar]
  30. Renshaw R. W., Gonda M. A., Casey J. W. Structure and transcriptional status of bovine syncytial virus in cytopathic infections. Gene. 1991 Sep 15;105(2):179–184. doi: 10.1016/0378-1119(91)90149-6. [DOI] [PubMed] [Google Scholar]
  31. Rethwilm A., Erlwein O., Baunach G., Maurer B., ter Meulen V. The transcriptional transactivator of human foamy virus maps to the bel 1 genomic region. Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):941–945. doi: 10.1073/pnas.88.3.941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Saïb A., Canivet M., Giron M. L., Bolgert F., Valla J., Lagaye S., Périès J., de Thé H. Human foamy virus infection in myasthenia gravis. Lancet. 1994 Mar 12;343(8898):666–666. doi: 10.1016/s0140-6736(94)92657-3. [DOI] [PubMed] [Google Scholar]
  33. Saïb A., Périès J., de Thé H. A defective human foamy provirus generated by pregenome splicing. EMBO J. 1993 Nov;12(11):4439–4444. doi: 10.1002/j.1460-2075.1993.tb06129.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Saïb A., Périès J., de Thé H. Recent insights into the biology of the human foamy virus. Trends Microbiol. 1995 May;3(5):173–178. doi: 10.1016/s0966-842x(00)88916-7. [DOI] [PubMed] [Google Scholar]
  35. Schweizer M., Fleps U., Jäckle A., Renne R., Turek R., Neumann-Haefelin D. Simian foamy virus type 3 (SFV-3) in latently infected Vero cells: reactivation by demethylation of proviral DNA. Virology. 1993 Feb;192(2):663–666. doi: 10.1006/viro.1993.1084. [DOI] [PubMed] [Google Scholar]
  36. Weiss R. A. Foamy retroviruses. A virus in search of a disease. Nature. 1988 Jun 9;333(6173):497–498. doi: 10.1038/333497a0. [DOI] [PubMed] [Google Scholar]
  37. Weissenberger J., Altmann A., Meuer S., Flügel R. M. Evidence for superantigen activity of the Bel 3 protein of the human foamy virus. J Med Virol. 1994 Sep;44(1):59–66. doi: 10.1002/jmv.1890440112. [DOI] [PubMed] [Google Scholar]
  38. Weissenberger J., Flügel R. M. Identification and characterization of the Bel 3 protein of human foamy virus. AIDS Res Hum Retroviruses. 1994 May;10(5):595–600. doi: 10.1089/aid.1994.10.595. [DOI] [PubMed] [Google Scholar]
  39. Wybier-Franqui J., Tobaly-Tapiero J., Coronel A., Giron M. L., Chopin-Robert C., Peries J., Emanoil-Ravier R. Human foamy virus DNA forms and expression in persistently infected Dami megakaryocytic cells. AIDS Res Hum Retroviruses. 1995 Jul;11(7):829–836. doi: 10.1089/aid.1995.11.829. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES